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Abstract
Melanocortin receptor accessory protein 2 (MRAP2) is a transmembrane accessory 
protein predominantly expressed in the brain. Both global and brain-specific deletion 
of Mrap2 in mice results in severe obesity. Loss-of-function MRAP2 mutations have 
also been associated with obesity in humans. Although MRAP2 has been shown to 
interact with MC4R, a G protein-coupled receptor with an established role in energy 
homeostasis, appetite regulation and lipid metabolism, the mechanisms through 
which loss of MRAP2 causes obesity remains uncertain. In this study, we used two 
independently derived lines of Mrap2 deficient mice (Mrap2tm1a/tm1a) to further study 
the role of Mrap2 in the regulation of energy balance and peripheral lipid metabolism. 
Mrap2tm1a/tm1a mice have a significant increase in body weight, with increased fat and 
lean mass, but without detectable changes in food intake or energy expenditure. 
Transcriptomic analysis showed significantly decreased expression of Sim1, Trh, Oxt and 
Crh within the hypothalamic paraventricular nucleus of Mrap2tm1a/tm1a mice. Circulating 
levels of both high-density lipoprotein and low-density lipoprotein were significantly 
increased in Mrap2 deficient mice. Taken together, these data corroborate the role of 
MRAP2 in metabolic regulation and indicate that, at least in part, this may be due to 
defective central melanocortin signalling.
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Introduction
Melanocortin receptor accessory protein (MRAP) and its 
paralogue MRAP2 are a recently identified class of small, 
single-pass transmembrane domain accessory proteins 
(Chan et al. 2009, Novoselova et al. 2013). Both MRAP and 
MRAP2 have been shown to interact with the melanocortin 
receptors (MCRs), a family of G protein-coupled receptors 
(GPCRs) with diverse physiological function stimulated 
by pro-opiomelanocortin (POMC) derived peptide agonists 
such as adrenocorticotropin hormone (ACTH) and 
α-MSH (Cone 2005, Chan et al. 2009). Of the five MCRs 
(MC1R–MC5R), only the function of the melanocortin 2 
receptor (MC2R) is clearly recognized to be facilitated 
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by MRAPs (Metherell et  al. 2005, Chan et  al. 2009), 
although in-vitro data suggests a broader role in 
conjunction with all the MCRs (Chan et al. 2009, Sebag & 
Hinkle 2009, 2010).
MRAP is highly expressed in the adrenal gland and 
is essential for MC2R function. Mutations in MRAP 
are associated with familial glucocorticoid deficiency 
(OMIM#607398) (Metherell et  al. 2005). MRAP2 is 
predominantly expressed in the central nervous system 
and hypothalamus, in particular within the paraventricular 
nucleus (PVN), a region known to have a role in energy 
homeostasis (Chan et  al. 2009). Mice with global and 
brain-specific Mrap2 deletion developed marked obesity 
and rare loss-of-function or missense heterozygous variants 
in MRAP2 were also identified in humans with severe early-
onset obesity (Asai et al. 2013). This work demonstrated that 
MRAP2’s role in the control of body composition and growth 
is via MC4R signalling (Asai et al. 2013). Further evidence for 
a link with MC4R signalling came from a study on the role 
of Mrap2 in zebrafish feeding and growth (Sebag et al. 2013).
Given these data, the phenotype observed in Mrap2-
deficient mice is likely, at least in part, to be driven by 
disruption of central melanocortin signalling. However, 
some areas of uncertainty remain. In particular, the para-
doxical observation that the mutant mice become obese 
without detectable changes in food intake or energy 
 
Figure 1
Mrap2 gene disruption results in weight gain  
(A) Schematic of knockout-first strategy for Mrap2. 
A promoter driven cassette including lacZ and neo 
genes are inserted upstream of critical exon 4.  
(B) Q-RT-PCR in 129/Sv mice demonstrating (i) 
Mrap2 expression in a range of wild-type mouse 
tissues showing the highest expression levels in the 
hypothalamus, n = 3. (ii) reduced hypothalamic 
Mrap2 transcript in Mrap2tm1a/+ and Mrap2tm1a/tm1a 
compared with Mrap2+/+ mice (n = 3 per genotype); 
mean plotted ± s.e.m.; **P < 0.005; ***P < 0.0005).  
(C) Expression of Mrap2 in the hypothalamus of the 
wild-type 129/Sv Mrap2+/+ and Mrap2tm1a/tm1a mice 
as shown by in situ hybridization using coronal 
brain sections (approx. bregma – 0.6 mm). AS, 
antisense probe, S, sense probe as a 
negative control. Third ventricle indicated as 3 V, 
asterisk indicates position of the PVN, OC, optic 
chiasm; scale bars = 200 μm. (D) Weight curves of 
Mrap2tm1a/tm1a in both genders and genetic 
backgrounds illustrated. 129/Sv Mrap2tm1a/tm1a n > 8 
per genotype and gender, C57BL/6N Mrap2tm1a/tm1a 
n = 7 of each gender and genotype. (E) Total body 
weight gain of C57BL/6N Mrap2tm1a/tm1a mice by the 
age of 16 weeks, n = 7 for each gender/genotype 
(left) and appearance of the mutant mice 
compared with the wild type (right). Data is 
presented as both box-and-whiskers plot (showing 
min-mean-max values, with the box representing 
the 25th and 75th percentiles), and as a scatter dot 
plot for individual values. P-values presented on 
graphs are either global P-values for genotype 
adjusted for multiple correction testing, or (in the 
cases of sexual dimorphism) the P-value is the 
impact of genotype for that sex.
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balance (Asai et al. 2013) requires exploration, as does the 
potential role of MRAP2 in peripheral cholesterol and lipid 
metabolism, a function known to be regulated by melano-
cortins (Nogueiras et al. 2007, Perez-Tilve et al. 2010). In 
this study, we have used an independently derived line 
of Mrap2-deficient mice (Mrap2tm1a/tm1a) on two different 
genetic backgrounds to further study the role of MRAP2 
in the regulation of energy homeostasis and the control 
of cholesterol and lipid metabolism.
Materials and methods
Generation of Mrap2-deficient mouse
Mice carrying the knockout-first conditional-ready allele 
Mrap2tm1a(EUCOMM)Wtsi (abbreviated to Mrap2tm1a) were 
generated on a C57BL/6N background as part of the Sanger 
Mouse Genetics Project (MGP) (Fig. 1A). Mice carrying the 
same Mrap2tm1a allele were generated separately on a 129S5/
SvEvBrdWtsi;129P2/OlaHsdWtsi background (abbreviated 
to 129/Sv). Detailed description of the Sanger Mouse 
Genetics Project methodology has been reported (Skarnes 
et al. 2011). Briefly, a promoter-containing cassette (L1L2_
Bact_P) was introduced upstream of the critical Mrap2 
exon 4 at position 87175333 of Chromosome 9, Build 
GRCm38 (Fig. 1A). The vectors containing Mrap2tm1a were 
electroporated into C57BL/6N derived JM8F6 and 129P2/
OlaHsd derived E14Tg2a embryonic stem (ES) cells. Correct 
ES cell gene targeting was confirmed by long-range PCR 
and quantitative PCR. Targeted ES cells were microinjected 
into blastocysts and used to generate chimeras. Germ-line 
transmission was confirmed by genotyping PCR analyses 
(http://www.knockoutmouse.org/kb/25/). Mice obtained 
from heterozygous intercross were genotyped for the 
Mrap2tm1a allele by PCR (Supplementary Table 1, see section 
on supplementary data given at the end of this article).
Animal husbandry
The care and use of all animals were carried out in 
accordance with the UK Home Office regulations, UK 
Animals (Scientific Procedures) Act 1986. Mice were kept 
under a standard 12 h light:12 h darkness cycle with food 
and water ad libitum unless otherwise stated. 129/Sv 
background mice were maintained in a facility at 22°C 
and fed a standard chow (SDS RM3, Essex, UK). Mice on 
a C57BL/6N background were maintained at 21°C ± 2°C, 
humidity 55% ± 10% and fed a standard rodent chow 
(LabDiets 5021-3, IPS, Richmond, VA, USA).
Metabolic phenotyping
Metabolic phenotyping was undertaken at two independent 
centres. In accordance to the 3R (replacement, reduction 
and refinement) principles of humane experimental 
technique and based on scientific objectives, not all 
procedures were performed on both lines. The genetic 
background of Mrap2tm1a mice used in each experiment 
have been specified previously.
Phenotyping using C57BL/6N mice was performed at 
the Wellcome Trust Sanger Institute as part of the MGP 
(White et al. 2013), whilst studies using 129/Sv background 
mice were carried out at the University of Cambridge Meta-
bolic Research Laboratories (MRL). For data arising from the 
MGP, a cumulative baseline was generated from controls of 
the same genetic background, age and sex. Seven male and 
seven female Mrap2tm1a mice were processed in five batches 
for each sex (one to three mice per batch) and were pheno-
typed unblinded as part of a larger mixed genotype group 
that included weekly wild-type controls, with the indi-
vidual mouse as the experimental unit. Animals for testing 
were randomly assigned to test sessions and operators. Mice 
were group housed to a minimum density of three per cage.
Body composition of 14-week-old anaesthetized 
C57BL/6N Mrap2tm1a mice were determined by dual-energy 
X-ray absorptiometry (DEXA) using a Lunar PIXImus2 
mouse densitometer (General Electric Medical Systems, 
Fitchburg, WI, USA).
After overnight fasting (approximately 16 h), intra-
peritoneal glucose tolerance tests (IPGTT) were carried 
out on 13-week-old mice. After taking a baseline glucose 
measurement, mice were given a single glucose injection 
(2 g/kg) and blood glucose measured at 15, 30, 60 and 
120 min (Accu-Chek Aviva, Roche).
Blood for plasma biochemistry was collected from 
16-week-old C57BL/6N animals into lithium-heparin 
tubes. Animals were not fasted unless otherwise indicated. 
Clinical blood chemistry was carried out using an 
Olympus AU400 chemistry analyser (Olympus). Insulin 
levels were measured by Mesoscale Discovery array 
technology platform.
Additional data relating to the C57BL/6N Mrap2tm1a/tm1a 
line can be found at http://www.mousepheno type.org/
data/genes/MGI:3609239. For studies at MRL, individual 
experiments were matched for age and sex of mice. The 
body weight and length were measured weekly since 
weaning. Food intake was carried out on 8-week-old 
single-housed acclimatized animals. Response to fasting 
was measured after mice were moved into clean cages, 
and food was removed at 07:00 for 24 h.
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Energy expenditure was determined at 8 weeks of 
age using indirect calorimetry. Animals were placed in 
a custom-built monitoring system based on their home 
cages (Ideas Studio, Cambridge, UK). Oxygen consump-
tion and carbon dioxide production was measured, and 
samples were taken at 18 min intervals for 48 h. Energy 
expenditure was calculated using indirect calori metry 
with the Elia and Livesey constants for respiratory 
quotie nt (Elia & Livesey 1992). Activity was assessed by 
beam breaks (beams 1.25 cm apart) and measurements 
were taken as total, rather than consecutive beam breaks.
Behavioural tests
Open field assessment was used to quantify spontaneous 
locomotor behaviour in a novel environment. The open 
field, custom-designed-walled, infra-red backlit arena 
75 cm2 (Tracksys Ltd., Nottingham, UK) was subdivided 
into a centre zone (42 cm2) with the remainder designated 
as border zone. Twenty-week-old 129/Sv background 
mice were recorded for a 20 min period using Noldus 
Ethovision-3 video tracking software. The position of 
the centre-point of the mouse within the open field was 
recorded. A mouse was considered to begin moving when 
its velocity surpassed 2 cm/s and stop moving when below 
1.75 cm/s. Mrap2tm1a/tm1a and their Mrap2+/+ controls were 
littermates housed in single-sex groups of three to five.
Histology, non-radioactive in-situ hybridization, 
immunohistochemistry and PVN stereotaxic counts
For haematoxilin-eosin (H&E) staining, tissues were 
fixed in 4% paraformaldehyde (PFA) (Sigma), washed, 
dehydrated and embedded into paraffin before sectioning 
to 7 µm. For Oil-Red-O staining, flash frozen liver 
was embedded into OCT (VWR), 10 µm cryosections 
were adhered onto slides (Thermo Fisher) and stained 
with Oil-Red-O (Sigma). Both staining techniques 
were performed according to standard protocols. Ucp1 
immunohistochemistry was carried out using brown fat 
paraffin sections anti-Ucp1 antibody (1/500) according 
to the manufacturer’s instructions (ab10983, Abcam) 
followed by detection using anti-rabbit HRP antibody 
(Thermo-Fisher) with DAB staining (Vector).
To generate riboprobes for in-situ hybridization (ISH), 
RNA was extracted from hypothalamus and cDNA pre-
pared. Full-length Mrap2 cDNA fragment (898 bp) was PCR 
amplified (Supplementary Table 1), ligated into pGEM-T 
easy vector (Promega), sequenced and then linearized 
with EcoRI or NotI (Promega). Digoxigenin (DIG)-labelled 
antisense and sense cRNA probes were synthesized by 
in-vitro transcription with T7 or SP6 RNA polymerases 
(Roche). Dissected brains were embedded into OCT and 
frozen in liquid nitrogen, 20 µm cryosections were cut 
onto slides and fixed with ice-cold 4% PFA for 20 min. 
Slides were then subjected to ISH as described previously 
(Gorrigan et al. 2011).
To determine the PVN neuron counts, brains of 
Mrap2tm1a/tm1a and wild-type littermates (three brains per 
group) were fixed in 4% PFA, cryoprotected with 20% 
sucrose and cryosectioned 20 μm each, starting from 
−0.58 mm to −1.22 mm to bregma (Franklin & Paxinos 
2012). After Nissl staining, the slides were visualized and 
images taken using Zeiss Axio Scope A1. The neurons 
within the PVN were then counted using ImageJ software 
(http://imagej.nih.gov/ij/). 
Laser-captured microdissection and RNA isolation
Mouse brains from 9-week-old, 129/Sv Mrap2tm1a/tm1a and 
Mrap2+/+ mice were dissected, immediately embedded 
into OCT and frozen in liquid nitrogen. Coronal sections 
(20 μm) covering the region from −0.58 mm to −1.22 mm 
caudal to bregma (Franklin & Paxinos 2012) were cut 
on a cryostat and mounted on Superfrost Plus slides 
(Thermo-Fisher). Frozen sections were fixed for 40 s in 
95% ethanol and then rehydrated (75% and 50% ethanol, 
30 s each). The slides were stained with 1% cresyl violet 
in 75% ethanol (w/v) for 45 s, dehydrated in a graded 
ethanol series (50, 75, 95, 100% for 30 s each), in 100% 
ethanol for 5 min and air-dried. Laser microdissection 
was performed using a P.A.L.M. MicroBeam (Zeiss). The 
PVN was collected into AdhesiveCap tubes (Zeiss). Total 
RNA was immediately isolated using the RNAqueous-
Micro Kit (Ambion). Quality and quantity of the total 
RNA samples were determined by the Agilent BioAnalyzer 
using PicoChip. RNAse free technique and RNAase free 
reagents were used throughout.
RNA microarray hybridization and analysis 
Fifteen nanograms of isolated RNA with the RNA Integrity 
Number of at least 6.5 (n = 4 for Mrap2+/+; n = 3 for 
Mrap2tm1a/tm1a) was converted into cDNA using Ovation 
PICO SL System V2 (NuGEN), which was then fragmented 
and labelled using Encore BiotinIL Module (NuGEN). 
About 1500 ng of each labelled product was then 
hybridized with MouseRef-8v2.0 Expression BeadChip 
Kit according to the manual and scanned using iScan 
(Illumina, San Diego, CA, USA). Raw image data were 
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converted to bsc format using Illumina GenomeStudio 
2011.1 software. Bonferroni correction with Family-Wise 
Error Rate (FWER) of 0.05 was applied to identify statistical 
significance of gene expression changes. Pathway analysis 
was performed using DAVID6.7 (http://david.abcc.ncifcrf.
gov/tools.jsp) and STRING 10 (http://string-db.org/).
Quantification of RNA by real-time quantitative PCR 
(Q-RT-PCR)
Dissected tissues were immediately frozen in liquid 
nitrogen, homogenized using Precellys24 (Precellys, 
Bertin Technologies, Paris, France) into RPL buffer 
(Qiagen) and the RNA was extracted with RNeasy Mini 
Kit (Qiagen). cDNA was produced with SuperScriptII (Life 
Technologies) and 50 ng of cDNA was used for RT-Q-PCR 
with TaqMan Universal MasterMix II and gene-specific 
TaqMan probes (Life technologies, Supplementary 
Table 2). The fold change related to Actin-b was calculated 
using 2-ΔΔTh method (Livak & Schmittgen 2001).
Protein quantification
White and brown fat tissues were homogenized using 
Precellys24 in ice-cold RIPA buffer (Sigma) containing 
phosphotase (Roche) and protease inhibitors cocktail 
(Sigma). Lysates were centrifuged for 20 min at 4°C before 
separation of the lipid layer. The SDS–PAGE samples 
were prepared with 2× Sample buffer (Sigma), heated at 
95°C for 5 min, centrifuged for 20 min at 4°C to separate 
samples from residual lipids and subjected to western 
blotting. The membrane was blocked with 5% bovine 
serum albumin in TBS (Life Technologies) for 1 h at 
22°C followed by incubation at 4°C overnight with the 
primary antibody: anti-ACTB antibody 1/10,000 (Abcam), 
anti-UCP1 1/5000 (Abcam) and antibodies for Fatty Acid 
and Lipid Metabolism and Lipolysis Activation (8334, 
8335 Cell Signaling Technology). After three washes, 
the membranes were probed with anti-mouse 680 and 
anti-rabbit 800 IRDye antibodies (LI-COR). The band 
intensities were quantified using Odyssey software.
Statistical analysis
All data were generated from the MGP utilized statistical 
analysis with RStudio running R version 3.1.2 and Phen-
stat package version 2.0.1. This uses a mixed-model frame-
work (Karp et al. 2012) to assess the impact of genotype 
on phenotype. The analysis was performed by loading 
the model without body weight, therefore analysing the 
absolute differences between genotypes whilst accounting 
for sex, using the model: Y = Genotype + Sex + Geno-
type × Sex. Multiple correction testing was performed on 
the global P-values using the Hochberg correction. Data 
is presented as both box-and-whiskers plot (showing 
min-mean-max values, with the box representing the 
25th and 75th percentiles), and as a scatter dot plot for 
individual values. P-values presented on graphs are either 
global P-values for genotype adjusted for multiple correc-
tion testing, or (in the cases of sexual dimorphism) the 
P-value is the impact of genotype for that sex.
For other data, males and females were assessed 
independently and the effect of genotype compared with 
wild-type controls was statistically tested using a two-
tailed Student’s t-test. For calorimetry data, multiple linear 
regression analysis (ANCOVA) was used. Data is plotted 
as mean ± s.e.m. and analysed using Microsoft excel and 
GraphPad Prism.
Results
Production of Mrap2-deficient mice
Mice carrying the mutant Mrap2tm1a allele were viable 
with expected homozygous mutant offspring born from 
heterozygous matings (21% C57BL/6N Mrap2tm1a/tm1a 
and 23% 129/Sv Mrap2tm1a/tm1a). Both female and male 
Mrap2tm1a/tm1a mice were fertile and did not exhibit any 
changes in skin or hair colour/appearance. The introduction 
of the knockout-first Mrap2tm1a allele resulted in targeted 
disruption of the critical exon 4 encoding the transmem-
brane domain of the protein. The predicted outcome would 
be a premature stop codon, thus producing a short 132 bp 
transcript that, if translated, would produce a 44 amino acid 
protein (predicted MW 5 kDa). Previous work demonstrated 
that such a protein was unlikely to be translated (Asai et al. 
2013). However, generation of hypomorphic mice have 
been demonstrated previously using the ‘knockout-first’ 
strategy targeting other genes (McIntyre et al. 2012, Chen 
et  al. 2013, White et  al. 2013). We therefore determined 
the expression of Mrap2 by Q-RT-PCR analysis using a 
TaqMan probe spanning exons 4–5. cDNA generated from 
whole hypothalamus extracted from mice on an 129/Sv 
background revealed a low but detectable residual Mrap2 
transcript of Mrap2tm1a/tm1a within homozygous mice (13%, 
range 11–16%), whilst heterozygotes Mrap2tm1a/+ mice had 
approximately half of the Mrap2 transcript expression 
compared with Mrap2+/+ (Fig. 1B).
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Mrap2 is predominantly expressed in the paraventricular 
nucleus of the hypothalamus
Mrap2 RNA expression was studied in wild-type mice tissues 
(Fig.  1B). The highest expression level was detected in 
the hypothalamus with substantial expression observed 
in the pituitary gland. Mrap2 expression was also detected 
in the cortex, cerebellum and adrenal gland. Kidney, 
testes, thymus and pancreas had very low expression 
levels whilst expression in white fat, liver, brown fat and 
skin was undetectable (Fig.  1B). ISH using a full-length 
Mrap2 probe showed visible Mrap2 RNA expression in the 
PVN of Mrap2+/+ mice on a 129/Sv background, which was 
absent in Mrap2tm1a/tm1a mice (Fig. 1C).
Mrap2 deficiency results in obesity in both C57BL/6N 
and 129/Sv background
Before weaning, there was no difference in body weight 
between wild-type and Mrap2tm1a/tm1a mice (Fig.  1D). 
However, in both genetic backgrounds and in both 
sexes, Mrap2tm1a/tm1a mice had a significant increase in 
body weight from 6 weeks of age. By 16 weeks of age 
on a C57BL/6N background, mean body weight in 
male wild-type mice was 32.2 g, compared with 42.5 g 
in Mrap2tm1a/tm1a mice; the corresponding weights in 
females were 25.4 g and 38.7 g, respectively (Fig.  1E). 
Similarly, on a 129/Sv background, mean body weight in 
male wild-type mice was 29.1 g, compared with 45.1 g in 
Mrap2tm1a/tm1a mice; the corresponding weights in females 
were 24.4 g and 36.9 g, respectively.
In C57BL/6N, this increase in body weight was as a 
result of a significant increase in both fat and lean mass 
(Fig.  2A and D). C57BL/6N Mrap2tm1a/tm1a females had 
twice the fat/body weight ratio of Mrap2+/+ controls and 
Mrap2tm1a/tm1a males displayed a 1.5-fold increase (Fig. 2A 
and B) with clear increase in adipocyte size macroscopically 
(Fig. 2C). No difference in bone mineral content or density 
was observed in either sex (Fig. 2E). Body length was signi-
ficantly increased in female, but not male Mrap2tm1a/tm1a 
 
Figure 2 
Increased fat content and lean mass in Mrap2tm1a/tm1a 
mice at 14 weeks. (A) Increased fat mass in mutant 
C57BL/6N mice. (B) Fat mass represented as a 
percentage of body weight. (C) Adipocyte 
hypertrophy as demonstrated by H&E histology of 
peripheral fat (representative image of inguinal 
white fat from 129/Sv mice). Scale bars = 200 μm.  
(D) Increased lean mass and (E) no difference in 
bone mineral density or content (data not shown) in 
Mrap2tm1a/tm1a mice (C57BL/6N) compared with 
Mrap2+/+. (F) Increased body length in the female 
mutant mice only (C57BL/6N). n = 7 for each 
Mrap2tm1a/tm1a group, 34 for female Mrap2+/+ and 35 
for Mrap2+/+ controls gender/genotype. P-values 
presented on graphs are either global P-values for 
genotype adjusted for multiple correction testing, or 
(in the cases of sexual dimorphism) the P-value is the 
impact of genotype for that sex. ***P = 0.0005; NS, 
not significant.
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mice (Fig.  2F). On the 129/Sv background, a significant 
increase in fat mass was recorded in both male and female 
Mrap2tm1a/tm1a mice compared with wild-type controls with 
no change in lean mass observed (data not shown).
Mrap2-deficient mice display little difference in food 
intake and energy expenditure compared with wild-type 
control mice
Activation of the melanocortin system has a role in both 
feeding behaviour in both ad libitum conditions and in 
re-feeding after fasting. To determine if loss of Mrap2 
affects feeding behaviour in either situation, the food 
intake and body weight of 8-week-old male and female 
129/Sv mice were monitored over a period of 60 h. For 
the first 24 h, food was freely available, after which mice 
were fasted for 24 h followed by reintroduction of food 
(Fig. 3A, B, C and D).
Neither female nor male Mrap2tm1a/tm1a mice exhibited 
changes in food intake when compared with wild-type 
controls over the entire period. Further, Mrap2tm1a/tm1a 
mice did not show any difference in the rate of weight loss 
upon fasting compared with the wild-type mice. However, 
interestingly, during re-feeding after a fast, Mrap2tm1a/tm1a 
male mice did not re-gain weight as fast as the wild-type 
males (Fig. 3C and D).
Total energy expenditure measurements versus lean 
mass or total body weight did not show significant changes 
between the genotypes/sex (Supplementary Fig.  1). 
Analysis of respiratory quotient over a period of 48-h 
demonstrated that it did not differ between Mrap2tm1a/tm1a 
and their Mrap2+/+ littermates (Supplementary Fig. 2). In 
keeping with a lack of change in energy expenditure, there 
was no difference between Mrap2tm1a/tm1a and Mrap2+/+ mice 
in the expression level of Ucp1 mRNA and UCP1 protein 
levels in brown adipose tissue of age-matched animals, 
despite differences in morphology (Supplementary Fig. 3).
Locomotor activity measurements (average beam 
breaks in a 5 min time period) demonstrated that male 
129/Sv Mrap2tm1a/tm1a mice, compared with wild-type, 
moved significantly more during the daytime (Fig.  4A). 
No difference was observed in females. 
Mrap2tm1a/tm1a mice display behavioural changes when 
presented with a novel environment
To further examine the locomotor activity as well as novel 
environment exploration and anxiety-related behaviour, 
20-week-old 129/Sv Mrap2tm1a/tm1a mice were subjected 
to an open field exploration test during the light phase. 
This recapitulated the sex-specific difference in locomotor 
activity between female and male Mrap2tm1a/tm1a mice 
(Fig. 4B and C). Mrap2tm1a/tm1a male mice spent more time 
moving and covered a greater distance compared with 
Mrap2+/+ mice. Although Mrap2tm1a/tm1a male mice appeared 
to spend more time traversing the centre of the open field 
 
Figure 3 
Food intake and energy expenditure balance in 
Mrap2+/+, Mrap2tm1a/+ and Mrap2tm1a/tm1a mice. 
Body weight dynamics of female (A) Mrap2+/+ 
n = 6; Mrap2tm1a/+ n = 4; Mrap2tm1a/tm1a n = 10 and 
male (B) Mrap2+/+ n = 6; Mrap2tm1a/+ n = 7; 
Mrap2tm1a/tm1a n = 6 mutant mice and their food 
intake (C and D) in response to a 24 h fast (129/Sv 
background). P < 0.05.
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than controls, the difference was not significant, P = 0.075 
(Fig. 4C and D). There was no difference in thigmotactic 
behaviour in the females, and Mrap2tm1a/tm1a mice of both 
sexes displayed no differences in gait, circling and rearing 
behaviour (data not shown).
Mrap2-deficient mice are Sim1 deficient
To further explore what might be the driving changes in 
body composition in Mrap2-deficient mice, we undertook 
transcriptomic analysis of laser microdissection PVN 
from 9-week-old 129/Sv Mrap2tm1a/tm1a mice and wild-type 
littermates (Fig. 5A). Mice of a 129/Sv genetic background, 
less prone to developing obesity-related co-morbidity, 
were used to reveal the effect of Mrap2 deficiency without 
secondary changes caused by hyperinsulinaemia and/or 
elevated glucose. We confirmed the changes observed in 
laser-capture material by undertaking Q-RT-PCR on whole 
hypothalamus extracted from a separate, second population 
of 129/Sv Mrap2tm1a/tm1a mice and wild-type littermates. 
Expression of genes that did not show any changes by 
microarray, such as Sf-1 and Pomc, were also confirmed by 
Q-RT-PCR as additional controls (Supplementary Fig. 4).
We could not detect significant changes in Mc4r 
mRNA expression in the PVN of Mrap2tm1a/tm1a mice due 
to the high variability between mice within each group 
(Fig.  5B). However, we found that Sim1 mRNA level in 
the PVN of Mrap2tm1a/tm1a mice was less than 50% of that 
observed in wild-type littermates (Fig. 5C). Sim1 is respon-
sible for the late stages of the differentiation of oxytocin 
(Oxt), arginine vasopressin (Avp), corticotrophin-releasing 
hormone (Crh), thyrotropin-releasing hormone (Trh) and 
somatostatin neurons (Sst) (Michaud et al. 1998). In keep-
ing with this, in Mrap2tm1a/tm1a mice, PVN expression levels 
of Oxt, Avp, Trh and Crh were significantly decreased com-
pared with the wild-type. Sst expression in Mrap2tm1a/tm1a 
was unchanged compared with Mrap2+/+ mice, although 
results were variable within the cohort (n = 3 per group). 
Analysis of RNA from whole hypothalami (Fig. 5D) reca-
pitulated these findings, except for Crh expression levels, 
which did not reach statistical significance. All changes 
were confirmed in both sexes (data not shown).
 
Figure 4 
Male Mrap2tm1a/tm1a mice locomotor activity 
analysis. (A) Beam breaks/5 min in male (left, 
Mrap2+/+ n = 9; Mrap2tm1a/+ n = 7; Mrap2tm1a/tm1a 
n = 11) and female (right, Mrap2+/+ n = 6; 
Mrap2tm1a/+ n = 4; Mrap2tm1a/tm1a n = 10) mice are 
shown, with male Mrap2tm1a/tm1a mice 
demonstrating significantly increased locomotor 
activity in their home cages during the daytime. 
(B) Open field assessment of Mrap2tm1a/tm1a mice 
also indicate a significant increase in total time 
moving and distance travelled over 20 min in 
males (left), when compared with Mrap2+/+ 
littermates, but not females (right). 
(C) Representative activity traces of the centre-
point of individual male mice (left) and female 
mice (right) in the open field. The colour of the 
trace indicates the velocity of the mouse from 
0 cm/s (blue) to 20 cm/s (pink). The centre of  
the open field is indicated by a dashed box.  
(D) Neither male (left) nor female Mrap2tm1a/tm1a 
mice (right) displayed a significant difference in 
time spent in areas of the open field, compared 
with wild-type controls. N number for B–D is eight 
per group/gender, *P < 0.05.
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It is known that SIM1 is implicated in the development 
of the PVN and Sim1+/– mice exhibit a smaller PVN with 
reduced neuron number compared with their wild-type lit-
termates (Michaud et al. 2001). We could not find morpho-
logical changes or a reduction in the number of neurons 
in the PVN of Mrap2tm1a/tm1a mice compared with wild-type 
(Fig.  5E and F), suggesting that unlike Sim1+/–, a lack of 
Mrap2 does not cause underdevelopment of the PVN.
Mrap2 deficiency increases circulating HDL  
and LDL cholesterol
Macroscopically, the livers of Mrap2tm1a/tm1a mice were 
visibly pale in both sexes in both 129/Sv and C57BL/6N 
backgrounds, and the histological analysis showed lipid 
accumulation (Fig.  6A and B). There is recent evidence 
that the central melanocortin system directly controls 
peripheral lipid metabolism and circulating cholesterol 
(Nogueiras et  al. 2007, Perez-Tilve et  al. 2010). We 
therefore studied the cholesterol and lipid profile in 
C57BL/6N Mrap2tm1a/tm1a mice. The blood triacylglyceride 
levels (TAG) were not significantly different in 
Mrap2tm1a/tm1a mice compared with wild-type (Fig.  6C). 
However, total circulating cholesterol in Mrap2tm1a/tm1a 
mice was significantly higher than in wild-type controls 
of both sexes (Fig. 6D). HDL was elevated in both sexes 
with a greater percentage increase in females (Fig.  6E). 
LDL was significantly increased in male and female 
Mrap2tm1a/tm1a mice (Fig.  6F). NEFA-C levels were not 
significantly different between Mrap2tm1a/tm1a and Mrap2+/+ 
mice of either sex (Fig. 6G), whilst glycerol concentration 
was increased to a similar degree in mutant mice of both 
sexes (Fig.  6H). To investigate whether high cholesterol 
levels were due to a decrease in cholesterol re-uptake 
in the liver or an increase in cholesterol synthesis, we 
analysed the expression of the HDL scavenger receptor 
Scarb1, LDL receptor (Ldlr) and the key transcription factor 
of cholesterol biosynthesis Srebp2 (Shimomura et al. 1998) 
in the livers of 129/Sv Mrap2tm1a/tm1a mice. Interestingly, 
Srebp2 mRNA levels were increased in the livers of female 
Mrap2tm1a/tm1a mice, whereas Scarb1 and Ldlr levels were 
similar to the wild type (Fig.  6I). Expression analysis of 
livers from male Mrap2tm1a/tm1a mice showed lower levels 
of Ldlr mRNA whereas Scarb1 and Srebp2 transcript were 
similar to the wild-type male littermates (Fig. 6I).
To study white fat function, we tested the protein 
levels and phosphorylarion state of enzymes involved 
in lipogenesis and fatty acid synthesis as well as 
phosphorylation of the rate-limiting enzyme for lipolysis 
of hormone sensitive lipase (HSL). Phosphorylation of 
 
Figure 5 
Mrap2 is involved in Mc4r regulation in the 
hypothalamus. (A) An example of the 
hypothalamic section stained with cresyl violet 
before the microdissection (left panel) and after 
(right panel). Asterisks show the position of the 
PVN, 3 V-third ventricle, the scale bars are 150 μm. 
(B) Mc4r expression level in the PVN (Mrap2+/+ 
n = 3, Mrap2tm1a/tm1a n = 3) and in the whole 
hypothalamus (Mrap2+/+ n = 4, Mrap2tm1a/tm1a n = 4) 
as determined by the qPCR. (C) Expression of Sim1, 
Trh, Oxt, Avp, Crh and Sst in the PVN of 129/Sv wild 
type (n = 4) and Mrap2tm1a/tm1a (n = 3) mice. The 
data are represented as the mean of the 
microarray fluorescence values (±s.e.m.), normalized 
to the wild type for each gene. *P < 0.05; 
**P < 0.005; ***P < 0.0005. (D) Expression of Sim1, 
Trh, Oxt, Avp, Crh and Sst in the whole 
hypothalamus of the wild-type and Mrap2tm1a/tm1a 
mice as determined by the qPCR. Data from male 
mice n = 4 per genotype is shown. (E) Morphology 
of the PVN of 129/Sv Mrap2tm1a/tm1a mice (right 
panel) compared with the wild type as shown by 
representative images of coronal brain sections 
(approx. bregma –0.8 mm) stained by Nissl. (F) 
Average PVN area size (left graph) and stereotaxic 
counts of Nissl positive cells (right graph) in the 
PVN of the mutant 129/Sv mice (n = 3) and their 
wild-type littermates (n = 3).
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ATP-citrate lyase (ACL), an enzyme responsible for the 
synthesis of cytosolic acetyl-CoA that serves lipogenesis 
and cholesterolgenesis pathways (reviewed in Chypre et al. 
2012), was increased in white fat of female Mrap2tm1a/tm1a  
mice but not in Mrap2tm1a/tm1a male mice (Fig. 7A and B, 
Supplementary Fig. 5A and B).
HSL phosphorylation is known to be important for 
the enzyme activation and therefore lipolysis (Egan et al. 
1992). The proportion of HSL phosphorylated on S563, 
S565 and S660 was analysed and it was found that the 
proportion of S660 phosphorylated HSL was three times 
lower in white fat of female Mrap2tm1a/tm1a mice compared 
with the wild type (Fig. 7C and D). Phosphorylation on 
other residues was not changed and male Mrap2tm1a/tm1a 
mice did not have changes in HSL phosphorylation on 
any residues tested (Supplementary Fig. 5C, D, E and F).
Analysis of glucose homeostasis in Mrap2-deficient mice
Mrap2tm1a/tm1a mice of both sexes on a C57BL/6N 
background fed on a chow diet from weaning display 
elevated fasting plasma insulin concentration with 
higher fasting blood glucose at 13 weeks of age compared 
with Mrap2+/+ mice (Fig. 7E and F). Glucose clearance in 
 
Figure 6 
Mrap2tm1a/tm1a mice exhibit fatty liver and changes 
in cholesterol metabolism. Morphological changes 
in the liver of 129/Sv Mrap2tm1a/tm1a mutant mice as 
shown by H&E staining (A) and Oil Red O (B), 
suggesting lipid accumulation in Mrap2tm1a/tm1a. 
Scale bars = 200 μm. (C, D, E, F, G and H) Circulating 
TAG, total cholesterol, HDL, LDL, NEFA-C and 
Glycerol in 16-week C57BL/6N Mrap2tm1a/tm1a mice 
are shown, n = 7 for each Mrap2tm1a/tm1a group, 38 
for female Mrap2+/+ and 35 for Mrap2+/+ controls 
gender/genotype. The P-values presented on 
graphs are either global P-values for genotype 
adjusted for multiple correction testing, or (in the 
cases of sexual dimorphism) the P-value is the 
impact of genotype for that sex. NS, not 
significant. *P < 0.05; **P < 0.005; ***P < 0.0005; 
NS, not significant. (I) Elevated expression levels of 
Srebp2 in Mrap2tm1a/tm1a female mice, reduced Ldlr 
in male Mrap2tm1a/tm1a mice and expression levels 
of Scarb1 in female mice and male mice (n = 4 for 
each genotype/gender, *P < 0.05, NS, not 
significant).
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response to an IP glucose bolus (Fig. 7G and H) appeared 
delayed, although statistical analysis of the area under the 
curve was only significant in female mice.
Discussion
In this study, we report the generation and characterization 
of a murine model with a targeted Mrap2 allele (knockout-
first Mrap2tm1a(EUCOMM)Wtsi). The construct used here is a Tm1a 
allele, which theoretically can still allow transcriptional 
read through (White et al. 2013). We detected low Mrap2 
expression within Mrap2tm1a/tm1a homozygous mice and in 
the absence of a suitable antibody we cannot rule out the 
possibility that the animals studied were indeed ‘strong 
hypomorphs’ rather than of complete knockouts.
Mrap2tm1a/tm1a mutant mice on both C57/BL6N and 
129/Sv background display severe early-onset obesity with 
a significantly increased fat mass, consistent with a recent 
report of Mrap2-knockout mice (Asai et al. 2013). Unlike 
Mrap2–/– mice on a 129/Sv genetic background (Asai et al. 
2013), our C57BL/6N Mrap2tm1a/tm1a display elevated fast-
ing insulin and blood glucose concentrations. We believe 
that this is an evidence of an interesting interaction 
between the genetic backgrounds with Mrap2, which will 
form the basis of a future study.
Mrap2–/– mice have been reported previously 
to show no increased food intake or reduction in 
energy expenditure and thermogenesis to account 
for their increased body weight. In our assessment of 
8-week-old Mrap2tm1a/tm1a mice, we recapitulated and 
confirmed these  findings. We calculate that female 
Mrap2tm1a/tm1a mice gained more weight compared with 
the wild-type  mice  (females: 0.117 ± 0.041 g/day; males: 
0.096 ± 0.023 g/day). To achieve this, a female  mutant 
mouse would need to deposit 0.701 ± 0.246 kcal/day and a 
male mouse 0.578 ± 0.139 kcal/day (Flatt 1991). This would 
equate to an increase in food intake of 0.232 ± 0.081 g 
of standard chow (for females) and 0.191 ± 0.046 g (for 
males), which is within the measurable limits of food 
intake variation. Therefore, it is possible that the causative 
difference is below the threshold of the detection 
(Tschop et  al. 2012, Speakman 2013). Indeed, older 
animals that are significantly more obese than their wild-
type counterparts, and as a result would be expected to 
consume larger quantities, demonstrate a subtle increase 
in cumulative food intake when monitored over 50 days 
(Asai et  al. 2013). Additionally, our behavioural tests on 
separate cohorts of animals, independently analysed 
on two separate platforms, demonstrated sex-specific 
increased daytime locomotor and exploratory activity 
in Mrap2tm1a/tm1a male mice, which may indicate food-
seeking behaviour. These lines of evidence would point to 
hyperphagia being the key driver in the development of 
obesity. However, importantly, obesity in Mrap2-deficient 
animals clearly precede any change in food intake and in 
paired feeding studies Mrap2-deficient animals continue 
to gain more weight than their wild-type counterparts 
(Asai et al. 2013). It is only when further food restriction 
was undertaken did weight gain in mutant mice become 
equivalent to that of wild-type mice (Asai et  al. 2013). 
Intriguingly, this suggests a far more complex mechanism 
at play in Mrap2 null mice. 
Our transcriptomic analysis of the PVN of the mutant 
mice also favoured increased energy intake as being a more 
likely promoter of increased body weight. It was found 
that Sim1 expression levels were low in the PVN of the 
Mrap2tm1a/tm1a mice resembling Sim1 deficiency. The reduced 
expression of Sim1 and its associated neuropeptides cannot 
be secondary to obesity alone, as this was not observed in 
reported hypothalamic microarray data from obese mice fed 
in a high fat diet (Lee et al. 2010). SIM1 is a transcription 
factor that regulates development of the PVN, and Sim1–/– 
mice die due to the abnormal hypothalamic architecture 
(Michaud et  al. 2001). Heterozygous Sim1+/– mice exhibit 
a small PVN with reduced neuronal number and develop 
severe early-onset obesity due to hyperphagia and increased 
linear growth. They have an impaired response to MTII, 
an MC3R/MC4R agonist, indicative of a disrupted central 
melanocortin pathway (Holder et al. 2004, Kublaoui et al. 
2006a,b, Tolson et  al. 2010). Expression analysis of the 
PVN from Sim1+/– mice has shown an 80% decrease in Oxt 
expression and 20–40% decrease in Trh, Crh, Avp and Sst 
expression (Kublaoui et  al. 2008). Compared with Sim1+/– 
mice, we did not detect morphological changes within the 
PVN of Mrap2tm1a/tm1a mice. However, the levels of Oxt, Avp 
and Trh in Mrap2tm1a/tm1a mice PVN were reduced, consistent 
with low Sim1 expression levels. Interestingly, despite these 
changes and also the high expression of Mrap2 in the 
pituitary, we  found no evidence of pituitary dysfunction 
in Mrap2tm1a/tm1a mice. Progression through puberty and 
fertility appear unchanged in mutant mice, and thyroid 
hormone levels, T3 and T4, were normal (data not shown). 
Corticosterone concentrations were previously reported to be 
normal (Asai et al. 2013). This would suggest that the level of 
neuropeptide expression is sufficient for peptide production 
and physiological stimulation of downstream hormones, as 
exemplified by normal levels of T4 in the case of Trh. 
In contrast to the downstream effects, the change in 
neuropeptide expression is likely to play a direct role in 
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maintaining energy homeostasis as it is known that Oxt, 
Avp and Trh in the PVN have anorexigenic effects (reviewed 
in Valassi et al. 2008), and Oxt is thought to be key to the 
mechanism for the hyperphagia of Sim1+/− mice (Kublaoui 
et al. 2008). Overall, the changes in Sim1 provide further 
evidence that a central melanocortin pathway deficiency 
exists in Mrap2tm1a/tm1a mice as SIM1 has been considered 
to be downstream of MC4R signalling (Holder et al. 2004, 
Kublaoui et al. 2006a,b, Tolson et al. 2010). 
Modulation of MC4R has been shown to directly affect 
peripheral lipid metabolism. Mc4r–/– mice had elevated 
plasma cholesterol and HDL levels (Nogueiras et al. 2007, 
Perez-Tilve et al. 2010). Both sexes of Mrap2tm1a/tm1a mice 
displayed elevated circulating cholesterol although there 
is a suggestion that males and females partition choles-
terol into HDL differently, consistent with reports of sex 
differences in the hepatic control of cholesterol metabo-
lism (De Marinis et  al. 2008). Mrap2tm1a/tm1a female mice 
showed increased de novo hepatic lipogenesis; however, 
unlike female Mrap2tm1a/tm1a mice, male Mrap2tm1a/tm1a mice 
had low expression of liver LDL receptor, possibly reflect-
ing elevated circulating LDL levels.
 
Figure 7 
Phosphorylation of ACL and HSL are changed in 
female Mrap2tm1a/tm1a mice and insulin insensitivity 
in both genders observed at 13 weeks of age. (A) 
Analysis of ACL phosphorylation in white fat of 
the female mutant mice compared with the wild 
type by immunoblotting. (B) A significant increase 
is demonstrated in mutant mice by using band 
densitometry analysis of the ratio of 
phosphorylated to non-phosphorylated ACL 
normalized to β-actin. (C) Phosphorylation of HSL 
on S660 in white fat of the female mutant mice is 
decreased as assessed by western blotting. (D) 
Densitometry analysis of phosphorylated to 
non-phosphorylated HSL normalized to β-actin was 
calculated (n = 3 per genotype; 129/Sv). (E) Fasting 
plasma glucose and (F) fed-state plasma insulin are 
higher in C57BL/6N Mrap2tm1a/tm1a mutant mice of 
both genders associated with significantly elevated 
insulin levels (log transformed due to the range of 
values observed in Mrap2tm1a/tm1a male mice. (G&H) 
IPGTT performed on 13-week-old mice of both 
genders, delayed glucose clearance demonstrated 
in Mrap2tm1a/tm1a female mice but not statistically 
significant in male Mrap2tm1a/tm1a mice. n = 7 for 
each Mrap2tm1a/tm1a group, 39 for female Mrap2+/+ 
and 35 for Mrap2+/+ controls gender/genotype. 
P-values presented on graphs are either global 
P-values for genotype adjusted for multiple 
correction testing, or (in the cases of sexual 
dimorphism) the P-value is the impact of genotype 
for that sex. AUC, area under the curve; *P < 0.05; 
**P < 0.005; ***P < 0.0005; NS, not significant.
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Mrap2tm1a/tm1a female mice had increased ACL phos-
phorylation in white fat, a key modification that activates 
ACL catalytic activity (Berwick et al. 2002) and leads to 
an increase in de novo lipogenesis. Along with this change 
we found that phosphorylation of HSL on S660, which 
is phosphorylated by protein kinase A upon sympathetic 
nervous system activation (Anthonsen et  al. 1998), was 
decreased. It is possible that both changes in the liver and 
white adipocytes are due to the low sympathetic tone 
which is in part regulated via the central melanocortin 
system (Nogueiras et  al. 2007, Perez-Tilve et  al. 2010). 
Mrap2 is not expressed in white fat or liver and there-
fore is unlikely to influence de novo lipogenesis directly 
in these tissues, suggesting that MRAP2 may contribute 
to the melanocortin regulation of sympathetic outflow. 
The changes observed in white fat were only found in 
females and are thus unlikely to be the primary cause of 
MRAP2-associated obesity, although this might explain 
the greater severity of obesity in females.
Our study corroborates the role of MRAP2 in 
metabolism. The changes in cholesterol metabolism and 
transcriptomic profile in the PVN of Mrap2tm1a/tm1a mice 
support the notion that MRAP2 is involved in the MC4R 
signalling pathway in vivo. However, our data further 
highlights phenotypic differences between Mrap2-deficient 
and Mc4r-deficient mice. Despite both mice developing 
severe early-onset obesity, Mc4r–/– mice are clearly 
hyperphagic with decreased energy expenditure (Huszar 
et al. 1997, Balthasar et al. 2005), whilst Mrap2-deficient 
mice display no demonstrable hyperphagia or reduction 
in energy expenditure. We describe other additional 
pheno typic differences such as normal bone mineral 
content and density in Mrap2tm1a/tm1a mice in contrast to 
increased bone density in Mc4r–/– mice (Braun et al. 2012). 
Importantly, Asai and coworkers demonstrated that 
Mrap2–/– mice remain responsive to treatment with MTII, 
a MC3R/MC4R agonist, whilst the anorexic response to 
MTII is abolished in Mc4r–/– mice, suggesting at least some 
preservation of MCR function centrally (Marsh et al. 1999, 
Asai et  al. 2013). We also show sex-specific differences 
in glucose handling as well as an exploratory activity 
phenotype in Mrap2tm1a/tm1a mice. Taken together, our 
study points towards the likelihood of MC4R-independent 
mechanisms and possibly MCR-independent pathways in 
the pathogenesis of MRAP2-associated obesity.
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